ULTIVA

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug ULTIVA contains one active pharmaceutical ingredient (API):

1 Remifentanil UNII 5V444H5WIC - REMIFENTANIL HYDROCHLORIDE

Remifentanil is a selective mu-opioid agonist with a rapid onset and very short duration of action. The mu-opioid activity, of remifentanil, is antagonised by narcotic antagonists, such as naloxone. Read about Remifentanil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ULTIVA Powder for concentrate for solution for infusion	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01AH06	Remifentanil	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AH Opioid anesthetics
Discover more medicines within N01AH06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 505618040043117, 505618040043217
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.629-1-03-12, 5918-MEE-0221
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61488, 61489, 61490
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 199505, 199612, 199661
Country: FR	Base de données publique des médicaments	Identifier(s): 64569231, 68136868, 68201593
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 73122, 73125, 73128
Country: HK	Department of Health Drug Office	Identifier(s): 43301, 43302
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7334
Country: JP	医薬品医療機器総合機構	Identifier(s): 8219401D1021, 8219401D2028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1011444
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 541M98
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 45713, 45721, 45748
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7623, 7624
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100091092, 100091100, 100091123
Country: SG	Health Sciences Authority	Identifier(s): 09542P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 15493051H, 15493052H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522273379, 8699874080465, 8699874080472
Country: US	FDA, National Drug Code	Identifier(s): 67457-198, 67457-912, 67457-913, 67457-914
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/2.9/0078, 31/2.9/0079, 31/2.9/0080